These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
251 related articles for article (PubMed ID: 28282438)
1. A new Caenorhabditis elegans model of human huntingtin 513 aggregation and toxicity in body wall muscles. Lee AL; Ung HM; Sands LP; Kikis EA PLoS One; 2017; 12(3):e0173644. PubMed ID: 28282438 [TBL] [Abstract][Full Text] [Related]
2. Cytoplasmic aggregates trap polyglutamine-containing proteins and block axonal transport in a Drosophila model of Huntington's disease. Lee WC; Yoshihara M; Littleton JT Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3224-9. PubMed ID: 14978262 [TBL] [Abstract][Full Text] [Related]
3. Differential contributions of Caenorhabditis elegans histone deacetylases to huntingtin polyglutamine toxicity. Bates EA; Victor M; Jones AK; Shi Y; Hart AC J Neurosci; 2006 Mar; 26(10):2830-8. PubMed ID: 16525063 [TBL] [Abstract][Full Text] [Related]
4. Xyloketal-derived small molecules show protective effect by decreasing mutant Huntingtin protein aggregates in Caenorhabditis elegans model of Huntington's disease. Zeng Y; Guo W; Xu G; Wang Q; Feng L; Long S; Liang F; Huang Y; Lu X; Li S; Zhou J; Burgunder JM; Pang J; Pei Z Drug Des Devel Ther; 2016; 10():1443-51. PubMed ID: 27110099 [TBL] [Abstract][Full Text] [Related]
5. Oxidative stress is increased in C. elegans models of Huntington's disease but does not contribute to polyglutamine toxicity phenotypes. Machiela E; Dues DJ; Senchuk MM; Van Raamsdonk JM Neurobiol Dis; 2016 Dec; 96():1-11. PubMed ID: 27544481 [TBL] [Abstract][Full Text] [Related]
6. Suppression of polyglutamine-induced toxicity in cell and animal models of Huntington's disease by ubiquilin. Wang H; Lim PJ; Yin C; Rieckher M; Vogel BE; Monteiro MJ Hum Mol Genet; 2006 Mar; 15(6):1025-41. PubMed ID: 16461334 [TBL] [Abstract][Full Text] [Related]
7. TBK1 phosphorylates mutant Huntingtin and suppresses its aggregation and toxicity in Huntington's disease models. Hegde RN; Chiki A; Petricca L; Martufi P; Arbez N; Mouchiroud L; Auwerx J; Landles C; Bates GP; Singh-Bains MK; Dragunow M; Curtis MA; Faull RL; Ross CA; Caricasole A; Lashuel HA EMBO J; 2020 Sep; 39(17):e104671. PubMed ID: 32757223 [TBL] [Abstract][Full Text] [Related]
9. Proteostasis of Huntingtin in Health and Disease. Koyuncu S; Fatima A; Gutierrez-Garcia R; Vilchez D Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28753941 [TBL] [Abstract][Full Text] [Related]
10. Aggregation landscapes of Huntingtin exon 1 protein fragments and the critical repeat length for the onset of Huntington's disease. Chen M; Wolynes PG Proc Natl Acad Sci U S A; 2017 Apr; 114(17):4406-4411. PubMed ID: 28400517 [TBL] [Abstract][Full Text] [Related]
11. The polyglutamine domain is the primary driver of seeding in huntingtin aggregation. Skeens A; Siriwardhana C; Massinople SE; Wunder MM; Ellis ZL; Keith KM; Girman T; Frey SL; Legleiter J PLoS One; 2024; 19(3):e0298323. PubMed ID: 38483973 [TBL] [Abstract][Full Text] [Related]
12. Multiple discrete soluble aggregates influence polyglutamine toxicity in a Huntington's disease model system. Xi W; Wang X; Laue TM; Denis CL Sci Rep; 2016 Oct; 6():34916. PubMed ID: 27721444 [TBL] [Abstract][Full Text] [Related]
13. Novel polyglutamine model uncouples proteotoxicity from aging. Christie NT; Lee AL; Fay HG; Gray AA; Kikis EA PLoS One; 2014; 9(5):e96835. PubMed ID: 24817148 [TBL] [Abstract][Full Text] [Related]
14. Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. Faber PW; Alter JR; MacDonald ME; Hart AC Proc Natl Acad Sci U S A; 1999 Jan; 96(1):179-84. PubMed ID: 9874792 [TBL] [Abstract][Full Text] [Related]
15. Reduction of polyglutamine toxicity by TDP-43, FUS and progranulin in Huntington's disease models. Tauffenberger A; Chitramuthu BP; Bateman A; Bennett HP; Parker JA Hum Mol Genet; 2013 Feb; 22(4):782-94. PubMed ID: 23172908 [TBL] [Abstract][Full Text] [Related]
17. N-Terminal Fragments of Huntingtin Longer than Residue 170 form Visible Aggregates Independently to Polyglutamine Expansion. Chen MZ; Mok SA; Ormsby AR; Muchowski PJ; Hatters DM J Huntingtons Dis; 2017; 6(1):79-91. PubMed ID: 28339398 [TBL] [Abstract][Full Text] [Related]
18. Caenorhabditis elegans as a Model System for Discovering Bioactive Compounds Against Polyglutamine-Mediated Neurotoxicity. Wang Q; Zhang J; Jiang Y; Xiao Y; Li X; Mao X; Huang Z J Vis Exp; 2021 Sep; (175):. PubMed ID: 34633391 [TBL] [Abstract][Full Text] [Related]
19. HSP90 recognizes the N-terminus of huntingtin involved in regulation of huntingtin aggregation by USP19. He WT; Xue W; Gao YG; Hong JY; Yue HW; Jiang LL; Hu HY Sci Rep; 2017 Nov; 7(1):14797. PubMed ID: 29093475 [TBL] [Abstract][Full Text] [Related]
20. Profilin reduces aggregation and phase separation of huntingtin N-terminal fragments by preferentially binding to soluble monomers and oligomers. Posey AE; Ruff KM; Harmon TS; Crick SL; Li A; Diamond MI; Pappu RV J Biol Chem; 2018 Mar; 293(10):3734-3746. PubMed ID: 29358329 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]